SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-KSB includes “forward-looking statements” within the meaning of Section 27A of the United States Securities Act of 1933, as amended (the Securities Act) and Section 21E of the United States Securities Exchange Act of 1934, as amended (the Exchange Act). The forward-looking statements include statements regarding our expectations with respect to future development plans for our next generation product candidates, particularly the Levacor TM  Rotary VAD, the timing and scope of pre-clinical testing and clinical trials, our ability to secure additional funding or...